gip glp 1 agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Polyagonists Enable Increasingly Effective Treatment
Description
Thomsen C, Storm H, Holst JJ, Hermansen K
Although glycolysis contributes to glucose metabolism and supports cellular signaling, including activation of glucose transporters, it produces far less ATP than OXPHOS, yielding only two ATP molecules per glucose molecule [15,16]
Jebb and colleagues are among the first to trace this trajectory
Our new investigation shows it now protects the industry
Pharmacologic management
decreased the gluconeogenesis, and decreased plasma-free fatty acid's level, plasma triglyceride, total cholesterol levels and corticosterone level, while increasing plasma leptin (the satiety hormone)
